Palisade Bio (PALI)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Thomas Hallam
Employees:
6
20271 GOLDENROD LANE, STE 2024, GERMANTOWN, MD, 20876
301-366-4841

Palisade Bio is a late-stage biopharma company advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. The company was founded in 1996 and is headquartered in Germantown, Maryland.

Data derived from most recent annual or quarterly report
Market Cap 33.691 Million Shares Outstanding12.909 Million Avg 30-day Volume 464.168 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 10.91 / 0.54 Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from PALI instead.

View recent insider trading info

Funds Holding PALI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PALI BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

33 Thousand total shares from 9 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HALLAM THOMAS CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
7,592 2021-09-21 3

FINLEY JOHN DAVID CHIEF FINANCIAL OFFICER

  • Officer
40,718 2021-09-21 4

TRENSCHEL ROBERT J.

  • Director
14,999 2021-08-31 3

YUMA REGIONAL MEDICAL CENTER

  • 10% Owner
1,814,375 2021-08-19 1

NEAL JAMES R

  • Director
16,401 2021-04-27 2

WILLIAMS DONALD ALLEN

  • Director
14,609 2021-04-27 2

DAWSON MICHAEL JOHN CHIEF MEDICAL OFFICER

  • Officer
35,675 2021-04-27 2

DIAZ STEPHANIE

  • Director
14,609 2021-04-27 2

GRAY MARY ANN

  • Director
6,000 2021-04-01 1

MAZZO DAVID J

  • Director
6,000 2021-04-01 1

CSIMMA CRISTINA

  • Director
6,000 2021-04-01 1

WEI BINXIAN

  • Director
6,000 2021-04-01 1

SMITH SANDFORD D

  • Director
219,916 2019-07-01 0

OGILVIE SCOTT VARDE

  • Director
0 2019-07-01 0

OLDAKER WILLIAM CLYDE

  • Director
0 2019-07-01 0

CARTER KENNETH C EXECUTIVE CHAIRMAN

  • Officer
  • Director
0 2018-12-12 0

WESTREICH STANLEY

  • Director
0 2018-07-02 0

DALY RICHARD J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2017-11-07 0

LLOYD JONES JONATHAN BRIAN CHIEF FINANCIAL OFFICER

  • Officer
7,859 2017-03-24 0

GARR RICHARD CEO

  • Officer
  • Director
1,449,804 2016-01-27 0

JOHE KARL CHIEF SCIENTIFIC OFFICER

  • Officer
  • Director
930,373 2015-11-19 0

SOHN CATHERINE A.

  • Director
106,952 2015-07-01 0

CONRON JOHN CHIEF FINANCIAL OFFICER

  • Officer
115,492 2011-01-28 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HALLAM THOMAS - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-22 19:35:08 -0400 2021-09-21 P 6,000 $2.49 a 7,592 direct -3.9683 5.1587 7.5397 5 -5.5556 4

FINLEY JOHN DAVID - Officer CHIEF FINANCIAL OFFICER

2021-09-22 19:36:52 -0400 2021-09-21 P 2,000 $2.44 a 14,396 direct -3.9683 5.1587 7.5397 5 -5.5556 4

TRENSCHEL ROBERT J. - Director

2021-09-13 18:40:55 -0400 2021-09-10 P 2,142 $2.98 a 14,999 direct -3.1142 -14.8789 0.0 1 -14.8789 6

TRENSCHEL ROBERT J. - Director

2021-09-13 18:40:55 -0400 2021-09-09 P 3,400 $2.89 a 12,857 direct -3.1142 -14.8789 0.0 1 -14.8789 6

TRENSCHEL ROBERT J. - Director

2021-09-13 18:40:55 -0400 2021-09-08 P 5,000 $2.75 a 9,457 direct -3.1142 -14.8789 0.0 1 -14.8789 6

TRENSCHEL ROBERT J. - Director

2021-09-13 18:40:55 -0400 2021-09-07 P 2,707 $2.78 a 4,457 direct -3.1142 -14.8789 0.0 1 -14.8789 6

TRENSCHEL ROBERT J. - Director

2021-09-13 18:40:55 -0400 2021-08-31 P 1,750 $2.75 a 1,750 direct -3.1142 -14.8789 0.0 1 -14.8789 6

FINLEY JOHN DAVID - Officer CHIEF FINANCIAL OFFICER

2021-08-30 14:01:44 -0400 2021-08-27 P 1,600 $2.63 a 3,996 direct 2.9304 5.8608 0.7326 9.8901 9 -13.9194 17

FINLEY JOHN DAVID - Officer CHIEF FINANCIAL OFFICER

2021-08-30 14:01:44 -0400 2021-08-27 P 8,400 $2.65 a 12,396 direct 2.9304 5.8608 0.7326 9.8901 9 -13.9194 17

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
PALISADE BIO INC PALI 2021-10-25 22:15:03 UTC -70.3895 70.4595 90000
PALISADE BIO INC PALI 2021-10-25 21:45:03 UTC -70.3895 70.4595 90000
PALISADE BIO INC PALI 2021-10-25 21:15:03 UTC -70.3895 70.4595 90000
PALISADE BIO INC PALI 2021-10-25 20:45:03 UTC -70.4896 70.5596 90000
PALISADE BIO INC PALI 2021-10-25 20:15:03 UTC -70.4896 70.5596 90000
PALISADE BIO INC PALI 2021-10-25 19:45:04 UTC -70.4896 70.5596 100000
PALISADE BIO INC PALI 2021-10-25 19:15:03 UTC -70.4896 70.5596 100000
PALISADE BIO INC PALI 2021-10-25 18:45:02 UTC -70.5084 70.5784 100000
PALISADE BIO INC PALI 2021-10-25 18:15:03 UTC -70.5084 70.5784 100000
PALISADE BIO INC PALI 2021-10-25 17:45:03 UTC -70.5084 70.5784 100000
PALISADE BIO INC PALI 2021-10-25 17:15:03 UTC -70.5084 70.5784 100000
PALISADE BIO INC PALI 2021-10-25 16:45:02 UTC -70.616 70.686 50000
PALISADE BIO INC PALI 2021-10-25 16:15:03 UTC -70.616 70.686 50000
PALISADE BIO INC PALI 2021-10-25 15:45:03 UTC -70.616 70.686 50000
PALISADE BIO INC PALI 2021-10-25 15:15:03 UTC -70.616 70.686 50000
PALISADE BIO INC PALI 2021-10-25 14:45:02 UTC -71.5812 71.6512 50000
PALISADE BIO INC PALI 2021-10-25 14:15:03 UTC -71.5812 71.6512 35000
PALISADE BIO INC PALI 2021-10-25 13:45:03 UTC -71.5812 71.6512 35000
PALISADE BIO INC PALI 2021-10-25 13:15:03 UTC -71.5812 71.6512 35000
PALISADE BIO INC PALI 2021-10-25 12:45:04 UTC -71.5812 71.6512 30000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments